Home › Myasthenia Gravis › South Carolina › Charleston
Myasthenia Gravis clinical trials in Charleston, SC
6 studies for Myasthenia Gravis are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
RecruitingPhase 3
- Clinical Trials of South Carolina - Charleston, Charleston
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
RecruitingPhase 2
- Clinical Trials of South Carolina - Neurology, Charleston
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1030, Charleston
- Site Number - 1015, Charleston
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RecruitingPhase 3
- Medical University of South Carolina, Charleston
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
RecruitingObservational study
- Medical University of South Carolina, Charleston
Vitaccess Real MG Registry
RecruitingObservational study
- Medical University South Carolina, Charleston
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Miami, FL7 studies
- New York City, NY7 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- Boston, MA6 studies
- Washington, DC6 studies
- San Francisco, CA6 studies
Other studies in Charleston
- Depression19 studies
- Stroke18 studies
- Heart Failure18 studies
- Non-Small Cell Lung Cancer16 studies
- Post-Traumatic Stress Disorder16 studies
- Cardiovascular Disease15 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Parkinson's Disease13 studies
- Interstitial Lung Diseases13 studies
- Breast Cancer12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.